| Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia. |
| Callén E, Samper E, Ramírez MJ, Creus A, Marcos R, Ortega JJ, Olivé T, Badell I, Blasco MA, Surrallés J |
| Human molecular genetics. 2002 ; 11 (4) : 439-444. |
| PMID 11854176 |
| |
| Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9. |
| Demuth I, Wlodarski M, Tipping AJ, Morgan NV, de Winter JP, Thiel M, Gräsl S, Schindler D, D'Andrea AD, Altay C, Kayserili H, Zatterale A, Kunze J, Ebell W, Mathew CG, Joenje H, Sperling K, Digweed M |
| European journal of human genetics : EJHG. 2000 ; 8 (11) : 861-868. |
| PMID 11093276 |
| |
| Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. |
| Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, Altay C, Poole J, Stones D, Kwee ML, van Weel-Sipman M, Havenga C, Morgan N, de Winter J, Digweed M, Savoia A, Pronk J, de Ravel T, Jansen S, Joenje H, Gluckman E, Mathew CG |
| Blood. 2000 ; 96 (13) : 4064-4070. |
| PMID 11110674 |
| |
| The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. |
| Futaki M, Igarashi T, Watanabe S, Kajigaya S, Tatsuguchi A, Wang J, Liu JM |
| Carcinogenesis. 2002 ; 23 (1) : 67-72. |
| PMID 11756225 |
| |
| Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment. |
| Futaki M, Watanabe S, Kajigaya S, Liu JM |
| Biochemical and biophysical research communications. 2001 ; 281 (2) : 347-351. |
| PMID 11181053 |
| |
| Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. |
| Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD |
| Molecular cell. 2001 ; 7 (2) : 249-262. |
| PMID 11239454 |
| |
| Fanconi anemia and DNA repair. |
| Grompe M, D'Andrea A |
| Human molecular genetics. 2001 ; 10 (20) : 2253-2259. |
| PMID 11673408 |
| |
| Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. |
| Koomen M, Cheng NC, van de Vrugt HJ, Godthelp BC, van der Valk MA, Oostra AB, Zdzienicka MZ, Joenje H, Arwert F |
| Human molecular genetics. 2002 ; 11 (3) : 273-281. |
| PMID 11823446 |
| |
| Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity. |
| Kuang Y, Garcia-Higuera I, Moran A, Mondoux M, Digweed M, D'Andrea AD |
| Blood. 2000 ; 96 (5) : 1625-1632. |
| PMID 10961856 |
| |
| The human XRCC9 gene corrects chromosomal instability and mutagen sensitivities in CHO UV40 cells. |
| Liu N, Lamerdin JE, Tucker JD, Zhou ZQ, Walter CA, Albala JS, Busch DB, Thompson LH |
| Proceedings of the National Academy of Sciences of the United States of America. 1997 ; 94 (17) : 9232-9237. |
| PMID 9256465 |
| |
| Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. |
| Medhurst AL, Huber PA, Waisfisz Q, de Winter JP, Mathew CG |
| Human molecular genetics. 2001 ; 10 (4) : 423-429. |
| PMID 11157805 |
| |
| Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9. |
| Nakanishi K, Moran A, Hays T, Kuang Y, Fox E, Garneau D, Montes de Oca R, Grompe M, D'Andrea AD |
| Experimental hematology. 2001 ; 29 (7) : 842-849. |
| PMID 11438206 |
| |
| Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. |
| Qiao F, Moss A, Kupfer GM |
| The Journal of biological chemistry. 2001 ; 276 (26) : 23391-23396. |
| PMID 11297559 |
| |
| A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. |
| Waisfisz Q, de Winter JP, Kruyt FA, de Groot J, van der Weel L, Dijkmans LM, Zhi Y, Arwert F, Scheper RJ, Youssoufian H, Hoatlin ME, Joenje H |
| Proceedings of the National Academy of Sciences of the United States of America. 1999 ; 96 (18) : 10320-10325. |
| PMID 10468606 |
| |
| The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange. |
| Wilson JB, Johnson MA, Stuckert AP, Trueman KL, May S, Bryant PE, Meyn RE, D'Andrea AD, Jones NJ |
| Carcinogenesis. 2001 ; 22 (12) : 1939-1946. |
| PMID 11751423 |
| |
| Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes. |
| Yamashita T, Nakahata T |
| International journal of hematology. 2001 ; 74 (1) : 33-41. |
| PMID 11530803 |
| |
| Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. |
| Yang Y, Kuang Y, Montes De Oca R, Hays T, Moreau L, Lu N, Seed B, D'Andrea AD |
| Blood. 2001 ; 98 (12) : 3435-3440. |
| PMID 11719385 |
| |
| The Fanconi anaemia group G gene FANCG is identical with XRCC9. |
| de Winter JP, Waisfisz Q, Rooimans MA, van Berkel CG, Bosnoyan-Collins L, Alon N, Carreau M, Bender O, Demuth I, Schindler D, Pronk JC, Arwert F, Hoehn H, Digweed M, Buchwald M, Joenje H |
| Nature genetics. 1998 ; 20 (3) : 281-283. |
| PMID 9806548 |
| |
